EUR/USD 1.15309
0.026%
Gold 4050.88
-1.284%
Oil 83.139
0.594%
USD/JPY 159.176
-0.208%
GBP/USD 1.34761
0.081%
GBP/JPY 214.510
-0.118%
Browse More
  • English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
On August 3, according to US media Semafor, a Senate continuing resolution introduced by Senators Collins and Murray has been passed. The bill would provide government funding until December 11. The bill blocks a new rule that would allow the government to cancel funding to states such as blue states. Collins stated that the bill "prevents the Office of Management and Budget (OMB) from enacting its proposed rule regarding federal financial aid." Murray stated, "This bill blocks the implementation of this corrupt new OMB appropriations rule during the continuing resolutions validity period. This proposed rule would systematically politicize federal funding and allow Trump administration officials to cancel appropriations at any time for any reason."August 3 - The China Earthquake Networks Center officially measured a 3.3-magnitude earthquake at 03:29 on August 3 in Gao County, Yibin City, Sichuan Province (28.55 degrees north latitude, 104.67 degrees east longitude), with a focal depth of 5 kilometers.August 3rd - According to the Financial Times, British pharmaceutical giant AstraZeneca has been exploring a merger with its US rival Bristol-Myers Squibb, which would create one of the worlds largest pharmaceutical groups with a market capitalization of nearly $400 billion. Sources familiar with the matter revealed that the two companies have been in talks regarding the merger for several months, and negotiations may reach an agreement soon, but there is also a possibility of delays or a breakdown. AstraZeneca is the UKs second-largest listed company by market capitalization, at approximately £196 billion, while Bristol-Myers Squibb has a market capitalization of approximately $133 billion. If the deal is completed, it will be one of the largest corporate mergers and acquisitions in history. This transaction would further accelerate the British pharmaceutical giants strategic shift towards the US market.August 3rd - Sources familiar with the matter revealed that Italian company Prysmian is in advanced talks to acquire US electrical manufacturer Atkore. Prysmian is finalizing preparations for an all-cash acquisition, which could be announced in the coming days. Sources indicated that despite the advanced stage of negotiations, the deal could still be delayed or ultimately fall through. Atkores stock has risen approximately 15% this year in New York, with a market capitalization of around $2.5 billion. Prysmians stock has risen more than a third this year, with a market capitalization of approximately €36.3 billion (about $41.8 billion).The Saudi Arabian and Iranian foreign ministers spoke by phone to discuss diplomatic efforts to de-escalate tensions.

The USD/JPY Currency Pair Swings in a 60-Pip Range as Bulls Reclaim 124.00 on a Positive Note

Drake Hampton

Apr 08, 2022 10:07

Tips

  • The USD/JPY is up 1.26 percent this week.

  • The greenback strengthens as investors shrug off geopolitical concerns.

  • Forecast for the USD/JPY Exchange Rate: As bulls, we are leaning upward and are aiming for the YTD high of 125.10.

 

As the Asian Pacific session opens, USD/JPY pair extends its weekly gains on broad US dollar strength. The USD/JPY remains strong at 124.15, after trading in a tight 55-pip range over the last three days as the Eastern Europe conflict between Russia and Ukraine enters its sixth day.

 

Asian market futures continue to trade higher, despite the ongoing Russia-Ukraine confrontation. Contrary to the positive tone of Asian market futures, which point to a stronger open, US equities concluded the afternoon in a divided mood. Investors shrugged aside Russia-Ukraine tensions on Thursday, despite Russian Foreign Minister Sergei Lavrov's complaint that Ukraine's new draft accord submitted to Russia does not meet Russia's demands on Crimea and Donbas. Meanwhile, recent reports indicate that Russia is regrouping soldiers in preparation for another offensive aimed at reclaiming Ukraine's eastern territories, Donetsk and Luhansk.

 

The North American session on Thursday featured Fed speakers, lead by St. Louis Fed President James Bullard, who stated that the Fed is still behind the curve in its efforts to contain inflation. Bullard said that by the second half of the year, he would like to see the Federal Funds Rate (FFR) at 3.5 percent.

 

Later that day, Chicago Fed President Charles Evans indicated that "we (the Fed) will reach neutral by the end of this year or early next."

 

On the Japanese docket, the Current Account for February and Consumer Confidence for March would be the headline economic data releases. On the US front, Wholesale Inventories for February will be released on a monthly basis. 

USD/JPY Forecast: Technical Analysis

The USD/JPY continues bullish, but the average daily range (ADR) has been 55 pips during the last three days. Daily moving averages (DMAs) below the spot price further reinforce the uptrend, and it's worth noting that the 100-DMA at 109.48 is on the verge of crossing over the 200-DMA at 109.60.

 

With that considered, the first resistance level for the USD/JPY would be 124.00. If the latter is breached, the March 29 daily high of 124.30 will be revealed, followed by the year-to-date high of 125.10.


image.png 


Suggestion